These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26851656)

  • 1. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
    Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
    Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
    Clin Microbiol Infect; 2012 Jul; 18(7):E248-50. PubMed ID: 22540149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
    Arendrup MC; Friberg N; Mares M; Kahlmeter G; Meletiadis J; Guinea J;
    Clin Microbiol Infect; 2020 Nov; 26(11):1464-1472. PubMed ID: 32562861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUCAST technical note on Amphotericin B.
    Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
    Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUCAST technical note on posaconazole.
    Arendrup MC; Cuenca-Estrella M; Donnelly JP; Hope W; Lass-Flörl C; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2011 Nov; 17(11):E16-7. PubMed ID: 21923779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.
    Arendrup MC; Kahlmeter G; Guinea J; Meletiadis J;
    Clin Microbiol Infect; 2021 Jan; 27(1):55-60. PubMed ID: 32916260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope W;
    Clin Microbiol Infect; 2012 Jul; 18(7):E246-7. PubMed ID: 22563750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUCAST technical note on voriconazole and Aspergillus spp.
    Hope WW; Cuenca-Estrella M; Lass-Flörl C; Arendrup MC;
    Clin Microbiol Infect; 2013 Jun; 19(6):E278-80. PubMed ID: 23413937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.
    Guinea J; Verweij PE; Meletiadis J; Mouton JW; Barchiesi F; Arendrup MC;
    Clin Microbiol Infect; 2019 Jun; 25(6):681-687. PubMed ID: 30268672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
    Mycoses; 2014 Jun; 57(6):377-9. PubMed ID: 24417759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUCAST technical note on anidulafungin.
    Arendrup MC; Rodriguez-Tudela JL; Lass-Flörl C; Cuenca-Estrella M; Donnelly JP; Hope W;
    Clin Microbiol Infect; 2011 Nov; 17(11):E18-20. PubMed ID: 21923778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.
    Jørgensen KM; Guinea J; Meletiadis J; Hare RK; Arendrup MC
    J Antimicrob Chemother; 2020 Sep; 75(9):2573-2581. PubMed ID: 32556315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW
    Drug Resist Updat; 2013 Dec; 16(6):81-95. PubMed ID: 24618110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.
    Espinel-Ingroff A; Turnidge J
    Rev Iberoam Micol; 2016; 33(2):63-75. PubMed ID: 27296911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility-testing in Aspergillus species.
    Lass-Flörl C; Perkhofer S
    Mycoses; 2008 Sep; 51(5):437-46. PubMed ID: 18422914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.